Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Dance Exercise as Novel Complementary Therapy for Parkinson's Disease (DANCE-PD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Daniel Tarsy, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT01163344
First received: July 14, 2010
Last updated: March 15, 2017
Last verified: March 2017
  Purpose
The purpose of this study is to gather data to see if so-called enriched forms of exercise programs such as dance is more effective in improving balance and quality of life in patients with idiopathic Parkinson's disease than regular exercise programs that are currently provided by physical therapists.

Condition
Parkinsons Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Dance Exercise as Novel Complementary Therapy for Parkinson's Disease

Resource links provided by NLM:


Further study details as provided by Beth Israel Deaconess Medical Center:

Primary Outcome Measures:
  • Balance and Gait improvement [ Time Frame: 10 weeks ]
    We seek to determine if balance and gait are improved as a result of dance therapy. This will be compared to the balance and gait data of group physical therapy.


Enrollment: 31
Study Start Date: July 2010
Study Completion Date: December 2015
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Dance Therapy Group
This will group will undergo dance therapy once a week for a series of 8 weeks.
Physical Therapy Group
This group will undergo physical therapy sessions once a week for a series of 8 weeks

Detailed Description:
Comparison of traditional PT to dance in people who have parkinsons disease to measure which is better for gait, balance and QOL.
  Eligibility

Ages Eligible for Study:   40 Years to 79 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
To qualify for this study, subject must have been diagnosed with Parkinson's Disease for 3 years or more, be less than 80 years of age, and have problems with gait and balance
Criteria

Inclusion Criteria:

  • Diagnosis of PD at least 3 years ago
  • Less than 80 years of age
  • Have gait and balance issues

Exclusion Criteria:

  • Diagnosis of PD for less than 3 years
  • 80 years of age or older
  • Not have gait and balance issues
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01163344

Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Investigators
Principal Investigator: Daniel Tarsy, MD Beth Israel Deaconess Medical Center
Principal Investigator: Veronique Vanderhorst, MD, PhD Beth Israel Deaconess Medical Center
  More Information

Additional Information:
Responsible Party: Daniel Tarsy, Principal Investigator, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT01163344     History of Changes
Other Study ID Numbers: 2010P000029
Study First Received: July 14, 2010
Last Updated: March 15, 2017
Individual Participant Data  
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Beth Israel Deaconess Medical Center:
Gait, balance, Parkinson's Disease

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on April 25, 2017